Related references
Note: Only part of the references are listed.Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies
Tim E. Moors et al.
MOLECULAR NEUROBIOLOGY (2019)
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
S. Pablo Sardi et al.
MOVEMENT DISORDERS (2018)
Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications
Roberta Balestrino et al.
NEUROSCIENTIST (2018)
Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development
Woojin Scott Kim et al.
FRONTIERS IN NEUROLOGY (2018)
GBA mutations in Parkinson disease: earlier death but similar neuropathological features
C. H. Adler et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
S. Pchelina et al.
NEUROSCIENCE LETTERS (2017)
Serum lipid alterations in GBA-associated Parkinson's disease
Leonor Correia Guedes et al.
PARKINSONISM & RELATED DISORDERS (2017)
Glucocerebrosidase Mutations in Parkinson Disease
Grace O'Regan et al.
JOURNAL OF PARKINSONS DISEASE (2017)
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2016)
What lysosomes actually tell us about Parkinson's disease?
Mathieu Bourdenx et al.
AGEING RESEARCH REVIEWS (2016)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease
Olive Jung et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease
Roberto A. Ortega et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Leukocyte glucocerebrosidase and β-hexosaminidase activity in sporadic and genetic Parkinson disease
Han-Joon Kim et al.
PARKINSONISM & RELATED DISORDERS (2016)
ER Stress and Autophagic Per turbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S LEParkinson's iPSC-Derived Dopamine Neurons
Hugo J. R. Fernandes et al.
STEM CELL REPORTS (2016)
GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A
Ting-Ting Du et al.
AUTOPHAGY (2015)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
Glucocerebrosidase and Parkinson disease: Recent advances
Anthony H. V. Schapira
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Lysosomal Alterations in Peripheral Blood Mononuclear Cells of Parkinson's Disease Patients
Nikolaos Papagiannakis et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
Tomoko Oeda et al.
NEUROBIOLOGY OF AGING (2015)
Parkinson risk in idiopathic REM sleep behavior disorder Preparing for neuroprotective trials
Ronald B. Postuma et al.
NEUROLOGY (2015)
Inflammatory dysregulation of blood monocytes in Parkinson's disease patients
Veselin Grozdanov et al.
ACTA NEUROPATHOLOGICA (2014)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
Edward I. Ginns et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Towfique Raj et al.
SCIENCE (2014)
Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro
Ritesh Thekkedath et al.
NANOMEDICINE (2013)
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
Michelle M. Mielke et al.
PLOS ONE (2013)
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
Michael A. Nalls et al.
JAMA NEUROLOGY (2013)
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine et al.
JAMA NEUROLOGY (2013)
Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses
Xianlin Han et al.
MASS SPECTROMETRY REVIEWS (2012)
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
R. N. Alcalay et al.
NEUROLOGY (2012)
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2011)
The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
Arash Velayati et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Kathleen S. Hruska et al.
HUMAN MUTATION (2008)
Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease
B Rudensky et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
Share Paper
